1h Free Analyst Time
The generic drugs market is forecasted to grow by USD 212.58 bn during 2023-2028, accelerating at a CAGR of 7.86% during the forecast period. The report on the generic drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by low-cost alternatives to branded medicines, increased outsourcing of drug discovery and development, and rising expiry of patents on branded drugs.
The generic drugs market is segmented as below:
By Route Of Administration
- Oral
- Injectables
- Topical
- Inhalers
By Type
- Small-molecule generics
- Biosimilars
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the generic drugs market covers the following areas:
- Generic drugs market sizing
- Generic drugs market forecast
- Generic drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Route of Administration
7 Market Segmentation by Type
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global generic drugs market: Abbott Laboratories, Amgen Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Aspen Pharmacare Holdings Ltd, Aurobindo Pharma Ltd., Baxter International Inc., Biocon Ltd., Cadila Pharmaceuticals Ltd., Cipla Ltd., Dr Reddys Laboratories Ltd., Eli Lilly and Co., Endo International Plc, Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Hikma Pharmaceuticals Plc, Lupin Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., PlantForm Corporation, Sanofi SA, STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is the advent of rpa (robotic process automation)."
According to the report, one of the major drivers for this market is the low-cost alternatives to branded medicines.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Amgen Inc.
- Amneal Pharmaceuticals Inc.
- Apotex Inc.
- Aspen Pharmacare Holdings Ltd
- Aurobindo Pharma Ltd.
- Baxter International Inc.
- Biocon Ltd.
- Cadila Pharmaceuticals Ltd.
- Cipla Ltd.
- Dr Reddys Laboratories Ltd.
- Eli Lilly and Co.
- Endo International Plc
- Fresenius SE and Co. KGaA
- GlaxoSmithKline Plc
- Hikma Pharmaceuticals Plc
- Lupin Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- PlantForm Corporation
- Sanofi SA
- STADA Arzneimittel AG
- Sun Pharmaceutical Industries Ltd.
- Teva Pharmaceutical Industries Ltd.
- Viatris Inc.
